- Home
- NMG vs EBS Comparison
NMG vs EBS Comparison
Compare NMG & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMG | EBS |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 414.7M | 413.3M |
| IPO Year | 2015 | 2006 |
Fundamental Metrics
Financial Performance| Metric | NMG | EBS |
|---|---|---|
| Price | $1.30 | $7.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.75 | ★ $12.00 |
| AVG Volume (30 Days) | 520.0K | ★ 656.7K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $103.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $5.87 |
| 52 Week High | $6.06 | $14.06 |
Technical Indicators
Market Signals| Indicator | NMG | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 37.81 | 39.76 |
| Support Level | $1.26 | N/A |
| Resistance Level | $1.67 | $8.59 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 18.33 | 31.03 |
Price Performance
Historical ComparisonAbout NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.